ArticleBiomarker research2022

Bone morphogenetic protein 2 is a new molecular target linked to non-alcoholic fatty liver disease with potential value as non-invasive screening tool.

Patricia Marañón et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.